CEPD References

CEPD 1 Primary & Secondary GN, vasculitis and autoimmune diseases

Immune-mediated kidney disease and COVID-19 – Hans-Joachim Anders, Munich, Germany

Risk assessment for progression of IgA nephropathy – Rosanna Coppo, Moncalieri, Italy

Neutrophil extracellular traps in immune-mediated glomerular diseases – Cees Van Kooten, Leiden, Netherlands

Anti-GBM disease – Mårten Segelmark, Lund, Sweden

Immune-mediated interstitial nephritis – Gema Maria Fernandez Juarez, Madrid, Spain

CEPD 2 Hypertension, diabetes, cardiovascular diseases in CKD

CEPD 3 CKD and bone mineral disorders in CKD

Bone biopsy in clinical decision-making – Ana Carina Ferreira, Queijas, Portugal

Bone turnover markers – clinical utility in CKD – Hanne Skou Jørgensen, Aarhus, Denmark

Bone imaging and risk assessment in CKD – Marie-Hélène Lafage-Proust, Saint-Etienne, France

PTH, a troublesome hormone – Markus Ketteler, Stuttgart, Germany

CEPD 4 Haemo- and Peritoneal Dialysis

CEPD 6 Acute Kidney Injury

No References lists available

CEPD 7 Electrolytes and urolithiasis

Calcium and magnesium disorders – Lucile Figueres, Nantes, France

Hypo- and hyperparathyroidism – Jean-Philippe Bertocchio, Paris, France

Disorders of phosphate balance – Sophie de Seigneux, Geneve, Switzerland

CEPD 8 Nephropathology

FSGS and minimal change glomerulopathy: what can nephropathology contribute? – Francesca Diomedi-Camassei, Rome, Italy

The spectrum of infection-associated glomerulonephritis – Jan Ulrich Becker, Cologne, Germany

Nephropathology of Covid-19 – Vanesa Bijol, New York, United States of America